Stay updated with the latest glenmark-pharmaceuticals news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on glenmark-pharmaceuticals topics.
New Delhi, Apr 9 (PTI) Glenmark Pharmaceuticals on Thursday said it has received final approval from the US health regulator for its generic version of progesterone vaginal inserts used in fertility treatments. The approval by the US Food and Drug Administration (USFDA) is for progesterone vaginal inserts of strength 100 mg, Glenmark Pharmaceuticals Ltd said in a regulatory filing. It has been determined by the USFDA to be bioequivalent and therapeutically equivalent to the reference listed dr ...Read More >
New Delhi [India], December 17 (ANI): The owners of the Birch by Romeo Lane nightclub in Goa's Arpora, brothers Gaurav Luthra and Saurabh Luthra, were taken from Indira Gandhi International (IGI) Airport in New Delhi to Goa on Wednesday morning after a Delhi court granted a 48-hour transit remand to the two accused. Visuals from early Wednesday morning at IGI Airport showed the brothers in police custody. Also Read | 'Agar Mai Aapki Dhoti...': Rakhi Sawant Fumes Over 'UP CM' Nitish Kumar's AYU ...Read More >
New Delhi [India], December 17 (ANI): The national capital, Delhi, witnessed a slight improvement in air quality on Wednesday morning, with the overall Air Quality Index (AQI) recorded at 328 at around 8 am, keeping it in the 'very poor' category, according to data from the Central Pollution Control Board (CPCB). The air quality improved slightly compared to Tuesday, as the AQI was 354 at 4 pm. However, large parts of the city remained enveloped in toxic smog, and the overall air quality contin ...Read More >
For the month, FII sold equities worth Rs 30,141.68 crore, while DII bought equities worth Rs 55,736.09 crore. The broader indices broke a three-week gaining streak and underperformed the main indices as markets remained under pressure throughout the week on worries over fresh tariffs on pharma, higher visa fees by the US, persistent trade concerns, and continued FII selling. For the week, Nifty50 plunged 672.35 points or 2.65 percent to finish at 24,654.70, while the BSE Sensex index declined ...Read More >
Mumbai: Benchmark stock indices Sensex and Nifty tumbled nearly one per cent on Friday, marking their sixth consecutive day of decline, following heavy selling in pharma and IT shares as US President Donald Trump announced 100 per cent duties on branded drugs from next month. The 30-share BSE Sensex tanked 733.22 points or 0.90 per cent to settle at a three-week low of 80,426.46. During the day, it dropped 827.27 points or one per cent to 80,332.41 points. The 50-share NSE Nifty tumbled 236.15 p ...Read More >
New Delhi: US President Donald Trump's decision to impose 100% tariffs on branded and patented drug exports has shaken Indian pharmaceutical markets, despite most of India's $10 billion US sales being in generics. The uncertainty lies in whether complex generics and specialty medicines will be included, a move that could directly impact leading players like Sun Pharma, Dr. Reddy's, Cipla, Zydus Lifesciences, and others. Stocks Facing Highest Exposure Dr. Reddy's emerges as the most vulnerable, ...Read More >
Glenmark Pharmaceuticals disclosed receiving a warning letter from the U.S. FDA for its Indore facility following a February inspection. The company clarified that the letter won't impact existing supplies or revenues. It also emphasized its commitment to compliance and noted no data integrity issues were found. Glenmark Pharmaceuticals shares may be in focus on Monday, July 14, after the company disclosed that it has received a warning letter from the U.S. Food and Drug Administration (FDA) fo ...Read More >
Mumbai: Shares of Glenmark Pharmaceuticals rallied as much as 20% and made a fresh lifetime high on Friday after it announced an exclusive licensing deal between Ichnos Glenmark Innovation (IGI) and AbbVie to develop and commercialise IGI's drug used for oncology and autoimmune diseases. The stock ended at ₹2,175.0 on Friday, up 14.3%. It made a record high of ₹2,284.8 during the day. "The deal marks a turning point for Glenmark and could lead to significant re-rating of the stock," said Ariji ...Read More >
New Delhi, Jul 11 (PTI) Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with AbbVie to commmercialise its underdevelopment drug aimed to treat cancer and autoimmune diseases in an up to USD 2 billion deal, one of the largest transactions in the pharma sector. The stock surged 9.99 per cent to hit its 52-week high as well as the upper circuit limit of Rs 2,095.65 on the BSE. At the NSE, the stock zoomed 10 per cent to Rs 2,094.40 -- i ...Read More >
New Delhi, Jul 10 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its arm Ichnos Glenmark Innovation, Inc has signed a licensing agreement with AbbVie for commercialisation of its lead investigational asset 'ISB 2001' targeted for treatment of cancer and autoimmune diseases. ISB 2001 has been developed using Ichnos Glenmark Innovation's (IGI) proprietary 'BEAT protein platform' for oncology and autoimmune diseases, Glenmark Pharmaceuticals said in a regulatory filing. Also Read | Bodoland ...Read More >
New Delhi, Jul 10 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its arm Ichnos Glenmark Innovation, Inc has signed a licensing agreement with AbbVie for commercialisation of its lead investigational asset 'ISB 2001' targeted for treatment of cancer and autoimmune diseases. ISB 2001 has been developed using Ichnos Glenmark Innovation's (IGI) proprietary 'BEAT protein platform' for oncology and autoimmune diseases, Glenmark Pharmaceuticals said in a regulatory filing. Under the agreement, ...Read More >
NEW DELHI: The Nifty Pharma index closed on a positive note on Monday. Shares of Natco Pharma Ltd.(up 4.78 per cent), Ipca Laboratories Ltd.(up 4.37 per cent), Laurus Labs Ltd.(up 3.29 per cent), Gland Pharma Ltd.(up 2.94 per cent) and Glenmark Pharmaceuticals Ltd.(up 2.49 per cent) ended the day as top gainers in the pack. On the other hand, J B Chemicals & Pharmaceuticals Ltd.(down 6.78 per cent), Dr. Reddy's Laboratories Ltd.(down 1.37 per cent), Sun Pharmaceutical Industries Ltd.(down 0.71 ...Read More >
New Delhi: The Enforcement Directorate (ED) on Friday carried out searches at 15 places in Mumbai and Kochi in connection with the Mithi River desilting scam that caused a wrongful loss of more than Rs 65 crore to the Brihanmumbai Municipal Corporation (BMC), official sources said. The massive crackdown is underway at the premises across Mumbai and Kochi linked to the accused and suspects as part of an ongoing probe into alleged financial irregularities. According to the sources, the searches ...Read More >
NEW DELHI: The Nifty Pharma index traded negative around 10:41AM(IST)on Friday in an upbeat market. Dr. Reddy's Laboratories Ltd.(up 1.24 per cent), Gland Pharma Ltd.(up 0.83 per cent), Ajanta Pharma Ltd.(up 0.56 per cent), Alkem Laboratories Ltd.(up 0.54 per cent) and Abbott India Ltd.(up 0.49 per cent) were among the top gainers. Laurus Labs Ltd.(down 1.57 per cent), Divi's Laboratories Ltd.(down 1.2 per cent), Granules India Ltd.(down 1.04 per cent), Glenmark Pharmaceuticals Ltd.(down 0.83 ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.